Teachers Advisors’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.43M Buy
2,474
+330
+15% +$138K ﹤0.01% 2136
2018
Q4
$601K Buy
2,144
+18
+0.8% +$7.12K ﹤0.01% 2432
2018
Q3
$1.02M Buy
2,126
+216
+11% +$92.6K ﹤0.01% 2303
2018
Q2
$865K Sell
1,910
-13
-0.7% -$8.24K ﹤0.01% 2402
2018
Q1
$1.13M Buy
1,923
+273
+17% +$170K ﹤0.01% 2156
2017
Q4
$1.02M Buy
1,650
+28
+2% +$20.1K ﹤0.01% 2217
2017
Q3
$1.49M Buy
1,622
+51
+3% +$45.3K ﹤0.01% 2012
2017
Q2
$1.47M Buy
1,571
+138
+10% +$135K ﹤0.01% 2001
2017
Q1
$1.36M Buy
1,433
+110
+8% +$102K ﹤0.01% 1993
2016
Q4
$1.06M Buy
1,323
+24
+2% +$21.6K ﹤0.01% 2150
2016
Q3
$1.1M Hold
1,299
﹤0.01% 2022
2016
Q2
$1.07M Buy
1,299
+173
+15% +$188K ﹤0.01% 1989
2016
Q1
$1.25M Hold
1,126
﹤0.01% 1863
2015
Q4
$1.4M Hold
1,126
﹤0.01% 1806
2015
Q3
$1.52M Buy
1,126
+15
+1% +$24.8K ﹤0.01% 1745
2015
Q2
$2M Buy
1,111
+259
+30% +$402K ﹤0.01% 1688
2015
Q1
$1.38M Buy
852
+85
+11% +$126K ﹤0.01% 1880
2014
Q4
$583K Hold
767
﹤0.01% 2362
2014
Q3
$304K Hold
767
﹤0.01% 2677
2014
Q2
$463K Sell
767
-29
-4% -$16.1K ﹤0.01% 2478
2014
Q1
$547K Buy
796
+77
+11% +$51.6K ﹤0.01% 2359
2013
Q4
$468K Buy
719
+93
+15% +$55.4K ﹤0.01% 2423
2013
Q3
$371K Buy
626
+68
+12% +$30.6K ﹤0.01% 2501
2013
Q2
$176K Buy
+558
New +$155K ﹤0.01% 2837

Other funds holding TCRT

Teachers Advisors's TCRT Position: Q1 2019 in Review

Teachers Advisors increased its Alaunos Therapeutics (TCRT) stake by 15% in Q1 2019, buying an estimated $138K and bringing the position to 2,474 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2136.

Teachers Advisors first reported a position in TCRT in Q2 2013 and has held it in 24 quarters since. The position peaked at $2M in Q2 2015. 124 funds tracked by Wall St. Rank hold TCRT as of Q1 2019.

  • Teachers Advisors held 2,474 shares of Alaunos Therapeutics worth $1.43M as of Q1 2019.
  • Teachers Advisors bought 330 Alaunos Therapeutics shares in Q1 2019, an estimated $138K.
  • Alaunos Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2136 holding.
  • Teachers Advisors first reported a position in Alaunos Therapeutics in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Alaunos Therapeutics position peaked at $2M in Q2 2015.
  • 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.